Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Yang Hui Ho"'
Autor:
Ting-Fang Che, Chao-Hua Chiu, Yu-Chung Wu, Jia-Yang Chen, Teh-Ying Chou, Yi-Chun Cheng, Chi-Lu Chiang, Chien-Sheng Huang, I-Shuan Tuang, Yang-Hui Ho, Jian-Hua Hong, Yen-Jang Huang, Hsiang-Ling Ho, Ying-Chih Chang
Publikováno v:
Lung Cancer. 178:198-205
Autor:
Muh-Hwa Yang, Mien-Chie Hung, Shyh-Kuan Tai, Hsiao-Jung Wang, Hsin-Yi Lan, Wen-Hao Hsu, Chih-Yi Lin, Shih-Pei Wu, Hua-Kuo Lin, Han-Syuan Lin, Pon-Bo Chen, Yang-Hui Ho, Chen-Hsi Chu, Chiou-Hwa Yuh, Wei-Lun Hwang, Dennis Shin-Shian Hsu
S1A: S1A: Gene expression profile of OECM1-CtxR cells (1.5 folds, 1955 identities); S1B: Cetuximab resistance signature (170 identities); S1C:Gene expression profiles in FaDu-Snail cells (2.5 folds with FPKM>1, 477 genes)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3937b2affed04060b99179ae45b11ada
https://doi.org/10.1158/1078-0432.22469225
https://doi.org/10.1158/1078-0432.22469225
Autor:
Muh-Hwa Yang, Mien-Chie Hung, Shyh-Kuan Tai, Hsiao-Jung Wang, Hsin-Yi Lan, Wen-Hao Hsu, Chih-Yi Lin, Shih-Pei Wu, Hua-Kuo Lin, Han-Syuan Lin, Pon-Bo Chen, Yang-Hui Ho, Chen-Hsi Chu, Chiou-Hwa Yuh, Wei-Lun Hwang, Dennis Shin-Shian Hsu
Purpose: In head and neck squamous cell carcinoma (HNSCC), the incidence of RAS mutation, which is the major cause of cetuximab resistance, is relatively rare compared with the other types of cancers, and the mechanism mediating acquired resistance i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::758019f380683d545fb97bad78b1d946
https://doi.org/10.1158/1078-0432.c.6527171.v1
https://doi.org/10.1158/1078-0432.c.6527171.v1
Autor:
Muh-Hwa Yang, Mien-Chie Hung, Shyh-Kuan Tai, Hsiao-Jung Wang, Hsin-Yi Lan, Wen-Hao Hsu, Chih-Yi Lin, Shih-Pei Wu, Hua-Kuo Lin, Han-Syuan Lin, Pon-Bo Chen, Yang-Hui Ho, Chen-Hsi Chu, Chiou-Hwa Yuh, Wei-Lun Hwang, Dennis Shin-Shian Hsu
Includes legends to 5 supplementary figures, supplementary methods, and supplementary references
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1eb8d8a43001e91753f44f0770b85f87
https://doi.org/10.1158/1078-0432.22469219.v1
https://doi.org/10.1158/1078-0432.22469219.v1
Autor:
Muh-Hwa Yang, Mien-Chie Hung, Shyh-Kuan Tai, Hsiao-Jung Wang, Hsin-Yi Lan, Wen-Hao Hsu, Chih-Yi Lin, Shih-Pei Wu, Hua-Kuo Lin, Han-Syuan Lin, Pon-Bo Chen, Yang-Hui Ho, Chen-Hsi Chu, Chiou-Hwa Yuh, Wei-Lun Hwang, Dennis Shin-Shian Hsu
Generation and characterization of the cetuximab-resistant head and neck cancer cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a75d0f71b635364955bd6abed06abdcd
https://doi.org/10.1158/1078-0432.22469240.v1
https://doi.org/10.1158/1078-0432.22469240.v1
Autor:
Ting-Fang Che, Chao-Hua Chiu, Yu-Chung Wu, Jia-Yang Chen, Teh-Ying Chou, Yi-Chun Cheng, Chi-Lu Chiang, Chien-Sheng Huang, I-Shuan Tuang, Yang-Hui Ho, Yen-Jang Huang, Hsiang-Ling Ho, Ying-Chih Chang
Publikováno v:
SSRN Electronic Journal.
Autor:
Muh Hwa Yang, Liang Chun Wu, Ying-Chih Chang, Dennis Shin Shian Hsu, Wen Hao Hsu, Ching Fei Li, Jia Yang Chen, Hsin Yi Lan, Shyh Kuan Tai, Yang Hui Ho
Publikováno v:
Nature Cell Biology. 21:251-262
Epithelial-mesenchymal transition (EMT) is a pivotal mechanism for cancer dissemination. However, EMT-regulated individual cancer cell invasion is difficult to detect in clinical samples. Emerging evidence implies that EMT is correlated to collective
Publikováno v:
Thrombosis and Haemostasis. 109:540-549
SummaryRAD001 is currently used as an immunosuppressant and anticancer drug. Megakaryocyte (MK) differentiation includes development from pluripotent stem cells to proliferation and differentiation toward MK formation and platelet maturation. Our pre
Autor:
Wen Hao Hsu, Han Syuan Lin, Chen Hsi Chu, Wei Lun Hwang, Chiou Hwa Yuh, Chih Yi Lin, Hsiao Jung Wang, Mien Chie Hung, Shyh Kuan Tai, Yang Hui Ho, Hsin Yi Lan, Pon Bo Chen, Shih Pei Wu, Muh Hwa Yang, Hua Kuo Lin, Dennis Shin Shian Hsu
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 23(15)
Purpose: In head and neck squamous cell carcinoma (HNSCC), the incidence of RAS mutation, which is the major cause of cetuximab resistance, is relatively rare compared with the other types of cancers, and the mechanism mediating acquired resistance i
Autor:
Yang-Hui Ho, 何仰惠
103
Cetuximab, a monoclonal antibody against the epidermal growth factor receptor EGFR extracellular domain, has been approved for the treatment of head and neck squamous cell carcinomas (HNSCC). However, many patients acquire resistance after C
Cetuximab, a monoclonal antibody against the epidermal growth factor receptor EGFR extracellular domain, has been approved for the treatment of head and neck squamous cell carcinomas (HNSCC). However, many patients acquire resistance after C
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/2f2vb3